Pregnancy in women with a mechanical heart valve : Data of the European society of cardiology registry of pregnancy and cardiac disease (ROPAC))

Journal article

van Hagen, Iris M., Roos-Hesselink, Jolien W., Ruys, Titia P E, Merz, W.M., Goland, S., Gabriel, H., Lelonek, M., Trojnarska, O., Al Mahmeed, Wael, Balint, H., Ashour, Zeinab, Baumgartner, Helmut, Boersma, E., Sliwa-Hahnle, Karen and et al. (2015). Pregnancy in women with a mechanical heart valve : Data of the European society of cardiology registry of pregnancy and cardiac disease (ROPAC)). Circulation. 132(2), pp. 132-142. https://doi.org/10.1161/CIRCULATIONAHA.115.015242
Authorsvan Hagen, Iris M., Roos-Hesselink, Jolien W., Ruys, Titia P E, Merz, W.M., Goland, S., Gabriel, H., Lelonek, M., Trojnarska, O., Al Mahmeed, Wael, Balint, H., Ashour, Zeinab, Baumgartner, Helmut, Boersma, E., Sliwa-Hahnle, Karen and et al
Abstract

Background— Pregnant women with a mechanical heart valve (MHV) are at a heightened risk of a thrombotic event, and
their absolute need for adequate anticoagulation puts them at considerable risk of bleeding and, with some anticoagulants,
fetotoxicity.

Methods and Results— Within the prospective, observational, contemporary, worldwide Registry of Pregnancy and Cardiac
disease (ROPAC), we describe the pregnancy outcome of 212 patients with an MHV. We compare them with 134 patients
with a tissue heart valve and 2620 other patients without a prosthetic valve. Maternal mortality occurred in 1.4% of the
patients with an MHV, in 1.5% of patients with a tissue heart valve (P=1.000), and in 0.2% of patients without a prosthetic
valve (P=0.025). Mechanical valve thrombosis complicated pregnancy in 10 patients with an MHV (4.7%). In 5 of these
patients, the valve thrombosis occurred in the first trimester, and all 5 patients had been switched to some form of heparin.
Hemorrhagic events occurred in 23.1% of patients with an MHV, in 5.1% of patients with a tissue heart valve (P<0.001),
and in 4.9% of patients without a prosthetic valve (P<0.001). Only 58% of the patients with an MHV had a pregnancy free
of serious adverse events compared with 79% of patients with a tissue heart valve (P<0.001) and 78% of patients without
a prosthetic valve (P<0.001). Vitamin K antagonist use in the first trimester compared with heparin was associated with a
higher rate of miscarriage (28.6% versus 9.2%; P<0.001) and late fetal death (7.1% versus 0.7%; P=0.016).

Conclusions— Women with an MHV have only a 58% chance of experiencing an uncomplicated pregnancy with a live
birth. The markedly increased mortality and morbidity warrant extensive prepregnancy counseling and centralization of
care

Keywordsheart defects, congenital; heart valves; pregnancy; prostheses and implants ; thrombosis
Year01 Jan 2015
JournalCirculation
Journal citation132 (2), pp. 132-142
PublisherLippincott Williams & Wilkins
ISSN0009-7322
Digital Object Identifier (DOI)https://doi.org/10.1161/CIRCULATIONAHA.115.015242
Web address (URL)https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.115.015242
Open accessPublished as non-open access
Research or scholarlyResearch
Page range132-142
Publisher's version
License
All rights reserved
File Access Level
Controlled
Output statusPublished
Publication dates
Online22 Jun 2015
Publication process dates
Accepted01 May 2015
Deposited31 May 2024
Supplemental file
License
All rights reserved
File Access Level
Controlled
Additional information

© 2015 American Heart Association, Inc

Funding - The ROPAC is a registry within the EORP. At the time of the registry, the following companies were supporting the EORP: Abbott Vascula Intl, Amgen, Bayer Pharma AG, Boehringer Ingelheim, Boston Scientific, the Bristol Myers Squibb/Pfizer alliance, Alliance Daiichi Sankyo Europe GmbH, Eli Lilly and Co, Menarini International Operations, Merck & Co Intl, Novartis Pharma, ResMed, Sanofi, and
Servier.

Place of publicationUnited States
Permalink -

https://acuresearchbank.acu.edu.au/item/90848/pregnancy-in-women-with-a-mechanical-heart-valve-data-of-the-european-society-of-cardiology-registry-of-pregnancy-and-cardiac-disease-ropac

Log in to edit

Restricted files

Publisher's version

Supplemental file

  • 5
    total views
  • 0
    total downloads
  • 5
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

First search for dyons with the full MoEDAL trapping detector in 13 TeV pp collisions
Acharya, B., Alexandre, J., Benes, P., Bergmann, B., Bernabéu, J., Bevan, A., Branzas, H., Burian, P., Campbell, M., Cecchini, S., Cho, Y. M., de Montigny, M., De Roeck, A., Ellis, J. R., El Sawy, M., Fairbairn, M., Felea, D., Frank, M., Hays, J., ... Wall, A.. (2021). First search for dyons with the full MoEDAL trapping detector in 13 TeV pp collisions. Physical Review Letters. 126(7), p. Article 071801. https://doi.org/10.1103/PhysRevLett.126.071801
Rheumatic heart disease in pregnancy
Mocumbi, Ana, Beaton, Andrea, Soma-Pillay, Priya, Dougherty, Scott and Sliwa, Karen. (2020). Rheumatic heart disease in pregnancy. In In Dougherty, Scott, Carapetis, Jonathan, Zühlke, Lisel and Wilson, Nigel (Ed.). Acute rheumatic fever and rheumatic heart disease pp. 171-193 Elsevier Inc.. https://doi.org/10.1016/B978-0-323-63982-8.00009-X
The European Society of Cardiology Heart Failure Association Study Group on Peripartum Cardiomyopathy - what has been achieved in 10 years
Sliwa, Karen, Bauersachs, Johann and Coats, Andrew J. S.. (2020). The European Society of Cardiology Heart Failure Association Study Group on Peripartum Cardiomyopathy - what has been achieved in 10 years. European Journal of Heart Failure. 22(7), pp. 1060-1064. https://doi.org/10.1002/ejhf.1912
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
Burstein, Roy, Henry, Nathaniel J, Collison, Michael L., Marczak, Laurie B., Sligar, Amber, Watson, Stefanie, Marquez, Neal, Abbasalizad-Farhangi, Mahdieh, Abbasi, Masoumeh, Abd-Allah, Foad, Abdoli, Amir, Abdollahi, Mohammad, Abdollahpour, Ibrahim, Abdulkader, Rizwan Suliankatchi, Abrigo, Michael R. M., Acharya, Dilaram, Adebayo, Oladimeji M, Adekanmbi, Victor, Adham, Davoud, ... Hay, Simon I.. (2019). Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. Nature. 574(7778), pp. 353-358. https://doi.org/10.1038/s41586-019-1545-0
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017 : A systematic analysis for the Global Burden of Disease Study 2017
James, Spencer L., Abate, Degu, Abate, Kalkidan Hassen, Abay, Solomon M., Abbafati, Cristiana, Abbasi, Nooshin, Abbastabar, Hedayat, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abdollahpour, Ibrahim, Abdulkader, Rizwan Suliankatchi, Abebe, Zegeye, Abera, Semaw F., Abil, Olifan Zewdie, Abraha, Haftom Niguse, Abu-Raddad, Laith Jamal, Abu-Rmeileh, Niveen M. E., Accrombessi, Manfred Mario Kokou, ... Murray, Christopher J. L.. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017 : A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 392(10159), pp. 1789-1858. https://doi.org/10.1016/S0140-6736(18)32279-7
Common values in assessing health outcomes from disease and injury : Disability weights measurement study for the Global Burden of Disease Study 2010
Salomon, Joshua A., Vos, Theo, Hogan, Daniel R., Gagnon, Michael, Naghavi, Mohsen, Mokdad, Ali, Begum, Nazma, Shah, Razibuzzaman, Karyana, Muhammad, Kosen, Soewarta, Farje, Mario Reyna, Moncada, Gilberto, Dutta, Arup, Sazawal, Sunil, Dyer, Andrew, Seiler, Jason, Aboyans, Victor, Baker, Lesley, Baxter, Amanda, ... Murray, Christopher J. L.. (2012). Common values in assessing health outcomes from disease and injury : Disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet. 380(9859), pp. 2129-2143. https://doi.org/10.1016/S0140-6736(12)61680-8